Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 30, 2018screamin' mentholCGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.Ideaz Llc · D-0835-2018Class IITerminatedMay 30, 2018screamin' hotCGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.Ideaz Llc · D-0834-2018Class IIITerminatedMay 30, 2018Zoma ShampooSubpotentMilbar Laboratories, Inc. · D-0833-2018Class IIITerminatedMay 30, 2018T Shampoo For Hair and BodySubpotentMilbar Laboratories, Inc. · D-0832-2018Class IITerminatedMay 30, 2018PrednisoLONE Sodium Phosphate Orally Disintegrating TabletsCGMP DeviationsMylan Pharmaceuticals Inc. · D-0831-2018Class IITerminatedMay 30, 2018PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mgCGMP DeviationsMylan Pharmaceuticals Inc. · D-0830-2018Class IITerminatedMay 30, 2018PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mgCGMP DeviationsMylan Pharmaceuticals Inc. · D-0829-2018Class IITerminatedMay 30, 20180.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Medical Care Renal Therapies Group, LLC · D-0827-2018Class IITerminatedMay 30, 2018Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mgLabeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.Exela Pharma Sciences LLC · D-0826-2018Class IITerminatedMay 30, 2018Loxapine CapsulesCGMP DeviationsMylan Pharmaceuticals Inc. · D-0825-2018Class IITerminatedMay 30, 2018Loxapine CapsulesCGMP DeviationsMylan Pharmaceuticals Inc. · D-0824-2018Class IITerminatedMay 30, 2018Loxapine CapsulesGMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contaminationMylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-0823-2018Class IITerminatedMay 30, 2018Loxapine CapsulesGMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contaminationMylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-0822-2018Class ITerminatedMay 30, 2018Rhino 69 Extreme 50000Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved...AMA Wholesale · D-0821-2018Class ITerminatedMay 23, 2018Piperacillin and Tazobactam for InjectionPresence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glassAuroMedics Pharma LLC · D-0926-2018Class ITerminatedMay 23, 2018Piperacillin and Tazobactam for InjectionSubpotent Drug: High Levels of Impurities Resulting in Decrease PotencyApotex Inc. · D-0840-2018Class ITerminatedMay 23, 2018Piperacillin and Tazobactam for InjectionSubpotent Drug: High Levels of Impurities Resulting in Decrease PotencyApotex Inc. · D-0839-2018Class IITerminatedMay 23, 2018Amlodipine and Benazapril HCL CapsulescGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedureMylan Pharmaceuticals Inc. · D-0820-2018Class IITerminatedMay 23, 2018Amlodipine and Benazapril HCL CapsulescGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedureMylan Pharmaceuticals Inc. · D-0819-2018Class IIITerminatedMay 23, 2018Riomet (metformin hydrochloride oral solution)Labeling: Not Elsewhere Classified: Sun Pharma has decided to initiate this recall in response to identified labeling discrepancies in the patient literature.Sun Pharmaceutical Industries, Inc. · D-0818-2018Class IITerminatedMay 23, 2018Hydrocortisone OintmentFailed Stability SpecificationsPerrigo New York · D-0817-2018Class IITerminatedMay 23, 2018Scopolamine Transdermal Therapeutic SystemDefective delivery systemL. Perrigo Company · D-0816-2018Class IITerminatedMay 23, 2018Kit for the Preparation of Technetium TC-99M MebrofeninFailed Stability SpecificationsPharmalucence, Inc. · D-0815-2018Class IITerminatedMay 23, 2018MD Complete Clarifying CleanserGMP DeviationsMilbar Laboratories, Inc. · D-0814-2018Class IITerminatedMay 23, 2018Naturmetic SPF 50 SunscreenGMP DeviationsMilbar Laboratories, Inc. · D-0813-2018Class IITerminatedMay 23, 2018Solar Defense Sheer Sunscreen Broad Spectrum SPF50GMP DeviationsMilbar Laboratories, Inc. · D-0812-2018Class IITerminatedMay 23, 2018B Prox 10 Anti-blemish WashMicrobial Contamination of Non-sterile ProductMilbar Laboratories, Inc. · D-0811-2018Class IIITerminatedMay 23, 2018Ferrous Sulfate 325 MG tabletPresence of Foreign Tablets/CapsulesAidarex Pharmaceuticals LLC · D-0810-2018Class IITerminatedMay 23, 2018Acetaminophen 300 mg with Codeine Phosphate 30 mg tabletsLabeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of...Prescript Pharmaceuticals, Inc. · D-0809-2018Class IITerminatedMay 23, 2018Clindamycin 300 mg capsulesLabeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of...Prescript Pharmaceuticals, Inc. · D-0808-2018Class IITerminatedMay 23, 2018Chlorhexidine 0.12% liquidLabeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of...Prescript Pharmaceuticals, Inc. · D-0807-2018Class IITerminatedMay 23, 2018Acetaminophen 300 mg with Codeine Phosphate 30 mg tabletsLabeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of...Prescript Pharmaceuticals, Inc. · D-0806-2018Class IITerminatedMay 23, 2018Clindamycin 150 mg capsulesLabeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of...Prescript Pharmaceuticals, Inc. · D-0805-2018Class IIITerminatedMay 23, 2018Calendula CreamLabeling: Labeling Error on Declared Strength; The outer carton (secondary packaging) statement of ingredients misstates the concentration of active ingredient at 7%...Boiron Inc. · D-0803-2018Class IITerminatedMay 23, 2018Sulfamethoxazole and Trimethoprim Tablets USPPresence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.) because a foreign matter...Sun Pharmaceutical Industries, Inc. · D-0802-2018Class ITerminatedMay 16, 2018Ampicillin and Sulbactam for InjectionPresence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing...AuroMedics Pharma LLC · D-0866-2018Class IITerminatedMay 16, 2018MinivelleDefective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients...Noven Pharmaceuticals, Inc. · D-0863-2018Class IITerminatedMay 16, 2018MinivelleDefective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients...Noven Pharmaceuticals, Inc. · D-0862-2018Class IIITerminatedMay 16, 2018OraVerseFailed Impurities/Degradation: This recall has been initiated due to an out of specification (OOS) result that was obtained for related substance (Phentolamide), a known...Septodont Inc. · D-0828-2018Class IITerminatedMay 16, 2018Macroaggregated albuminLack of Assurance of SterilityCoast Quality Pharmacy LLC · D-0801-2018